Please note that you will leave exlpharma.com and taken to a secure site for the transaction. If you would prefer to register by phone, please call 866-207-6528.
PROMOTING INNOVATION THROUGH ENHANCED COMMUNICATION BETWEEN FDA AND INDUSTRY DRUG DEVELOPMENT TO INCREASE POSSIBILITY OF FIRST CYCLE APPROVALS IN THE PROGRAM
- Dr Richard Guarino, Chief Medical Officer, VALIDUS PHARMACEUTICALS